Neuralert, co-founded by Professor Steven Messé, MD from Penn Medicine’s Department of Neurology and Research Assistant Professor James Weimer, PhD from Penn Engineering’s Department of Computer and Information Science, is developing a novel approach that addresses the problem of late or undetected stroke in hospitalized patients. The system uses non-invasive, wearable devices which continuously monitor at-risk hospitalized patients for stroke symptoms and automatically alerts clinical staff resulting in more rapid assessment and treatment of the patient.
The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) granted the Neuralert Monitor designation as a Breakthrough Device.
